We investigated the possible relationship between the susceptibility of cells to differentiation induced by phorbol 12-myristate 13-acetate (PMA) and the subcellular translocation of calcium-and phospholipid-dependent protein kinase (protein kinase C) activity from the cytosol to the membrane. These two events were analyzed in a number of human leukemia cell lines, including four cell variants of the promyelocytic cell line HL-60 that exhibit different degrees of susceptibility to PMA-induced differentiation. The phenotype of the differentiated cells was characterized by increased reactivity with monoclonal antibodies against maturationspecific cell surface antigens, increased nonspecific esterase activity, and acquisition of morphological cell maturation. Analysis of the subcellular distribution of protein kinase C activity in each of these cell types revealed that 90% of the kinase activity was present in the cytosolic fraction, with the remaining activity in the membrane fraction. Treatment of the differentiation-susceptible cells with 160 nM PMA resulted, within 5 min after treatment, in a >60% decrease in protein kinase C activity in the cytosolic fraction and a >1500% increase in the activity in the membrane fraction. No such subcellular redistribution of protein kinase C activity was found after treatment of the differentiation-resistant cells. On the basis of these findings, we suggest that the process of subcellular translocation of protein kinase C activity, initiated after the binding of PMA to this kinase, is required for the induction of cell differentiation by this phorbol diester.
Tumor-promoting phorbol diesters, including phorbol 12-myristate 13 -acetate (PMA), can bring about morphologic, antigenic, biochemical, and functional changes in some cultured mammalian cells (1) . In a number of these cell types, PMA can inhibit cell replication and induce cell differentiation (2) (3) (4) (5) (6) (7) (8) ; for example, in cells derived from human HL-60 promyelocytic leukemia (9) , PMA induces the cells to acquire a mature phenotype that resembles that of macrophages (4, 5, 10, 11) .
The biological activity of the phorbol diesters begins when they bind to specific cellular receptors (12) (13) (14) . Several lines of evidence have demonstrated that this receptor is a calcium-and phospholipid-dependent protein kinase termed protein kinase C (15) (16) (17) (18) . Kraft and coworkers (19, 20) reported that treatment of intact cells with phorbol diesters results in a translocation of this protein kinase from the cytosolic to the membrane fraction of the treated cells. Other studies have shown that phorbol diesters with active tumor-promoting activity induce this intracellular translocation, whereas inactive derivatives do not (21) . These studies implicate translocation of protein kinase C in the facilitation of the biological effects of phorbol diesters and a number of growth factors and hormones whose biological activity is mediated by protein kinase C (22) (23) (24) (25) (26) .
To study the mechanism of PMA-induced cell differentiation, and to analyze the role of protein kinase C translocation in this event, it is instrumental to use cell variants resistant to PMA-induced cell differentiation. These types of cell variants have been isolated from the HL-60 cell line (10, 11, 27) . Cells from these PMA-resistant variants differ from the susceptible parental cells in a number of biochemical and biophysical cell functions including membrane fluidity (28) , down-regulation of specific binding of phorbol esters (13) , and PMA-dependent protein phosphorylation (29) .
In the present studies, we have examined the relationship between cell susceptibility to PMA-induced differentiation and the subcellular distribution of protein kinase C activity in a series of human leukemia cell lines, including three stable PMA-resistant HL-60 cell variants. We tested another four human leukemia cell lines, in addition to the four HL-60 cell variants, for their susceptibility to PMA-induced cell differentiation. These cell lines included the parental HL-60, the myelocytic ML-2, the monocytic THP-1, and the T-lymphoid CEM-2 leukemia cell lines. Treatment of the HL-60, ML-2, and THP-1 cell lines with 3 nM PMA for 6 days caused the cells to acquire a mature phenotype resembling that of macrophages, whereas this treatment caused the CEM-2 cell line to acquire a phenotype resembling that of mature suppressor T lymphocytes (8, 11, 13, 32 Table 2) . These results indicate that PMA causes a translocation of the PBt2 receptor from the cytosol to the membrane in the differentiation-susceptible cells but not the resistant cells.
MATERIALS AND METHODS
PMA-Mediated Translocation of Protein Kinase C Activity from the Cytosol to the Membrane Fraction. Analysis of the subcellular distribution of the activity of protein kinase C showed that 90% of the activity was in the soluble fraction of the various leukemia cells. The cytosolic fractions obtained from the HL-60 cell variants catalyzed the formation of similar amounts of products, ranging from 2.4 to 2.9 nmol of phosphorylated residues per min per mg of protein (Table 3) .
Incubation of the differentiation-susceptible HL-205 cells with 160 nM PMA resulted in a time-dependent reduction in the activity of protein kinase C in the cytosolic fraction. This activity began to decrease within 2 min after the beginning of PMA treatment and reached its lowest level (40% of control level) 5-10 min after treatment (Table 3 , Fig. 1 ). The decrease in the cytosolic kinase C activity after 5 min of treatment with 1.6-160 nM PMA was dose-dependent (data not shown). In contrast, PMA caused little or no decrease in the cytosolic kinase C activity in the PMA-resistant HL-525, HL-534, and HL-402 cells (Table 3 , Fig. 1) .
Concomitant with the decrease in the cytosolic protein kinase C activity in the PMA-treated differentiation-susceptible cells, we observed a significant increase in this activity in the membrane fraction. Treatment of HL-205 cells with 160 nM PMA for 5 min resulted in a >15-fold increase in protein kinase C activity in the membrane fraction (Table 3 , Fig. 1 ). This increase in membrane-associated protein kinase C was also time- (Fig. 1) and dose-dependent (data not shown). In contrast, no significant increase in PMA-induced membraneassociated protein kinase C was observed in the HL-525, HL-534, or HL-402 cells, which are resistant to PMAinduced cell differentiation (Table 3 , Fig. 1) .
We also investigated the possibility that the differences between the susceptible and resistant cells in the subcellular distribution of protein kinase C activity after PMA treatment may result from the presence of enzyme inhibitors. We added cytosolic and membrane fractions from either untreated or PMA-treated HL-525 cells to those derived from either untreated or PMA-treated HL-205 cells, and vice versa, and then tested for protein kinase C activity. The results indicated that adding the fractions from the resistant cells to those of the susceptible cells and, reciprocally, adding fractions from the susceptible to those from the resistant cells did not alter the protein kinase C activities in the different cell fractions but rather yielded the expected mean values for the different mixtures. The PMA-induced reduction of the cytosolic and increase of the membranous protein kinase C activity in the susceptible HL-205 cells was also not caused by a direct effect of PMA on the enzyme activity, because addition of 160 nm PMA to the reaction mixture containing either fraction did not alter the kinase C activity.
We also analyzed the subcellular translocation of protein kinase C in HL-60, ML-2, THP-1, and CEM-2 cells, which are also susceptible to the induction of cell differentiation by PMA. The results indicated that treatment of these cells for 
DISCUSSION
Induction of cell differentiation by phorbol diesters and some related chemicals begins when they bind to a high-affinity and saturable receptor (11) (12) (13) (14) , which is a calcium-and phospholipid-dependent kinase (protein kinase C) (15) (16) (17) (18) . This binding is believed to activate the protein kinase, resulting in the phosphorylation of various cellular proteins (38) (39) (40) , including some that reside in or around the nucleus (29) . On the basis of these results, it was suggested (29) that induction of cell differentiation by PMA may require the migration of protein kinase C (PMA receptor) to the vicinity of the nucleus (nuclear membrane) where, through phosphorylation of regulatory proteins, the kinase causes the appropriate alterations in gene expression. These speculations can be tested by analyzing the subcellular distribution of protein kinase C in cells that are either susceptible or resistant to induction of differentiation by the phorbol esters.
We have, therefore, included in the present studies a series of human leukemia cells that differ in their susceptibility to induction of cell differentiation by PMA. PMA treatment of five different cell types, including HL-205 cells, all of which are susceptible to PMA-induced cell differentiation, resulted in a translocation of protein kinase C activity from the cytosol to the membrane fraction. In contrast, none of the three HL-60 cell variants that are resistant to PMA-induced cell differentiation exhibited such a translocation after PMA treatment.
The change in the subcellular distribution of protein kinase C may represent either a true translocation of the enzyme or the conversion of a loose association of protein kinase C with the membrane to a tight association (41, 42) . The translocation of protein kinase C could be detected within 2 min after PMA treatment, a time shorter than that required to saturate the phorbol diester receptors by its ligands (13) . These results suggest that the binding of phorbol ester to its receptor is coupled with translocation of protein kinase C to the membrane fraction that presumably also contains nuclear components. This association with this membrane fraction, which is rich in phospholipids, may be a key factor in enzyme activation.
On the basis of our results, we suggest that the translocation of protein kinase C activity, which occurs shortly after PMA treatment, is required, although not necessarily sufficient (43) , for the induction of cell differentiation by PMA, as well as for other biological activities induced by phorbol diesters in these and various other cell types.
